Steward Partners Investment Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
22,941
-1,673
-7% -$81.5K 0.01% 1158
2026
Q1
$1.06M Buy
24,614
+7,768
+46% +$334K 0.01% 1142
2025
Q4
$738K Buy
16,846
+801
+5% +$33.1K ﹤0.01% 1214
2025
Q3
$663K Buy
16,045
+6,459
+67% +$260K ﹤0.01% 1243
2025
Q2
$423K Sell
9,586
-1,753
-15% -$70.1K ﹤0.01% 1382
2025
Q1
$419K Buy
11,339
+4,289
+61% +$153K ﹤0.01% 1295
2024
Q4
$235K Buy
7,050
+330
+5% +$10.7K ﹤0.01% 1517
2024
Q3
$174K Buy
6,720
+3,064
+84% +$76.2K ﹤0.01% 1593
2024
Q2
$82.2K Buy
3,656
+75
+2% +$1.66K ﹤0.01% 1873
2024
Q1
$85K Buy
3,581
+286
+9% +$6.36K ﹤0.01% 1849
2023
Q4
$79K Buy
+3,295
New +$71.6K ﹤0.01% 1787
2023
Q1
– Sell
-40
Closed -$642 – 3344
2022
Q4
$642 Buy
+40
New +$652 ﹤0.01% 3172

Other funds holding EXEL

Steward Partners Investment Advisory's EXEL Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Exelixis (EXEL) stake by 6.8% in Q2 2026, selling an estimated $81.5K and leaving 22,941 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #1158.

Steward Partners Investment Advisory first reported a position in EXEL in Q4 2022 and has held it in 12 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Steward Partners Investment Advisory held 22,941 shares of Exelixis worth $1.25M as of Q2 2026.
  • Steward Partners Investment Advisory sold 1,673 Exelixis shares in Q2 2026, an estimated $81.5K.
  • Exelixis made up 0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1158 holding.
  • Steward Partners Investment Advisory first reported a position in Exelixis in Q4 2022 and has held it in 12 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.